Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas.
AUTOR(ES)
Andrew, S M
RESUMO
The problem of the differential diagnosis both of central nervous system haemangioblastomas and metastases of renal clear cell carcinomas was investigated by immunoperoxidase labelled antibody staining of five cases each of haemangioblastoma and metastatic renal carcinoma. Staining using anticarcinoembryonic antigen (CEA), antikeratin, antifactor VIII related antigen, and antibrush border was unhelpful. All five of the haemangioblastomas were negative and all five of the metastases were positive for epithelial membrane antigen (EMA), as defined by immunoperoxidase staining. This shows that commercially available anti-EMA monoclonal antibody is useful in distinguishing the two pathological entities.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=500137Documentos Relacionados
- Influence of site of origin of lung carcinomas on clinical presentation and central nervous system metastases.
- Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel.
- Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
- Papilloma Choroideum with Diffuse Central Nervous System Metastases
- Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis
